- Home
- TTNP vs RSLS Comparison
TTNP vs RSLS Comparison
Compare TTNP & RSLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTNP
- RSLS
- Stock Information
- Founded
- TTNP 1991
- RSLS 2002
- Country
- TTNP United States
- RSLS United States
- Employees
- TTNP N/A
- RSLS N/A
- Industry
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- RSLS Medical/Dental Instruments
- Sector
- TTNP Health Care
- RSLS Health Care
- Exchange
- TTNP Nasdaq
- RSLS Nasdaq
- Market Cap
- TTNP 3.0M
- RSLS 3.2M
- IPO Year
- TTNP 1996
- RSLS 2007
- Fundamental
- Price
- TTNP $3.79
- RSLS $4.52
- Analyst Decision
- TTNP
- RSLS Hold
- Analyst Count
- TTNP 0
- RSLS 1
- Target Price
- TTNP N/A
- RSLS N/A
- AVG Volume (30 Days)
- TTNP 41.9K
- RSLS 21.9K
- Earning Date
- TTNP 01-03-2025
- RSLS 11-14-2024
- Dividend Yield
- TTNP N/A
- RSLS N/A
- EPS Growth
- TTNP N/A
- RSLS N/A
- EPS
- TTNP N/A
- RSLS N/A
- Revenue
- TTNP N/A
- RSLS $8,183,000.00
- Revenue This Year
- TTNP N/A
- RSLS $17.47
- Revenue Next Year
- TTNP N/A
- RSLS $20.00
- P/E Ratio
- TTNP N/A
- RSLS N/A
- Revenue Growth
- TTNP N/A
- RSLS N/A
- 52 Week Low
- TTNP $3.03
- RSLS $4.09
- 52 Week High
- TTNP $14.80
- RSLS $29.00
- Technical
- Relative Strength Index (RSI)
- TTNP 48.54
- RSLS 44.77
- Support Level
- TTNP $3.14
- RSLS $4.35
- Resistance Level
- TTNP $3.38
- RSLS $5.19
- Average True Range (ATR)
- TTNP 0.22
- RSLS 0.33
- MACD
- TTNP 0.02
- RSLS 0.04
- Stochastic Oscillator
- TTNP 52.24
- RSLS 21.18
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.